Authors:
Graziano, SL
Tatum, A
Herndon, JE
Box, J
Memoli, V
Greene, MR
Kern, JA
Citation: Sl. Graziano et al., Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study, LUNG CANC, 33(2-3), 2001, pp. 115-123